8-K - GILEAD SCIENCES, INC. (0000882095) (Filer)
Published . Updated .
8-K - GILEAD SCIENCES filed an 8-K with the SEC on Oct 29 (a notice of a material company event).
Directly affected
- GILD Gilead Sciences+8.7% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Gilead Sciences belongs to, so it often moves with news about it.
- AMGN Amgen+19.0% 30d
Amgen is a peer of Gilead Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+35.5% 30d
Moderna is a peer of Gilead Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-16.8% 19d
argenx SE is a peer of Gilead Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Gilead Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
- BIIB Biogen+13.2% 19d
Biogen is a peer of Gilead Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| GILD | -5.75% | -3.93% | base | after close | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| AMGNNo price data for this ticker | — | — | — | — | — | — | — |
| MRNANo price data for this ticker | — | — | — | — | — | — | — |
| ARGXNo price data for this ticker | — | — | — | — | — | — | — |
| RVMDNo price data for this ticker | — | — | — | — | — | — | — |
| BIIBNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-29 AccNo: 0000882095-26-000037 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Gilead Sciences (GILD) since “8-K - GILEAD SCIENCES, INC. (0000882095) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Gilead Sciences (GILD) | three days earlier | -3.93% | final price |
| Gilead Sciences (GILD) | five days earlier | -5.75% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 80 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 37 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 64 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 78 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 62 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Biogen (BIIB), worth $1,001 - $15,000 on 24 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Biogen (BIIB) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Biogen (BIIB), worth $1,001 - $15,000 on 18 Aug 2026. That is 72 days before publication. Filed 1 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Gilead Sciences (GILD)
Companies tied to this story
- GILD Gilead Sciences
For “8-K - GILEAD SCIENCES, INC. (0000882095) (Filer),” Gilead Sciences (GILD) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> GILD
How “8-K - GILEAD SCIENCES, INC. (0000882095) (Filer)” reaches Gilead Sciences (GILD)
The 29 Oct 2026 story “8-K - GILEAD SCIENCES, INC. (0000882095) (Filer)” names Gilead Sciences (GILD) because of this story.
The link for Gilead Sciences (GILD) is this: SEC 8-K filing -> direct issuer disclosure -> GILD
Price levels for Gilead Sciences (GILD)
GILD traded between 142.61 and 160.83 across 20 sessions. The latest close on file is 159.20.
How solid “8-K - GILEAD SCIENCES, INC. (0000882095) (Filer)” looks
14 out of 100
“8-K - GILEAD SCIENCES, INC. (0000882095) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.